Z - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86923538
Serial Number
86923538
Registration Number
5324651
Word Mark
Z
Status
700 - Registered
Status Date
2017-10-31
Filing Date
2016-02-29
Registration Number
5324651
Registration Date
2017-10-31
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
240103 - Shields or crests with letters, punctuation or inscriptions contained therein or superimposed thereon.
Published for Opposition Date
2017-01-03
Law Office Assigned Location Code
M20
Employee Name
FOSDICK, GEOFFREY A
Statements
Indication of Colors claimed
The color(s) orange, and white is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a orange colored shield with the letter "Z" included in the shield in white.
Goods and Services
Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatory and antipyretic preparations; Anti-inflammatory gels; Anti-inflammatory salves; Anti-inflammatory sprays; Anti-rheumatism bracelets; Anti-rheumatism rings; Anti-rheumatism rings; Antibacterial cleaners; Antibacterial pharmaceuticals; Antibacterial spray; Antibiotic ointments; Antidiabetic preparations; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacterial preparations for medical and veterinary use; Bactericides; Bacteriological culture mediums; Bacteriological preparations for medical and veterinary use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Biological tissue cultures for medical purposes; Contrast media for in-vivo imaging; Contrast media for use with imaging medical equipment; Contrast media for use with medical ultrasound apparatus; Contrasting agent for ultrasound diagnostic imaging; Cord blood for medical purposes; Culture media for use in oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, oncology, rheumatoid arthritis, diabetes and metabolic disorders; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Dietetic sugar for medical use; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for oncology, rheumatoid arthritis, diabetes and metabolic disorders that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Genetic identity tests comprised of reagents for medical purposes; Imaging agents for magnetic resonance imaging (MRI); In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Insulin; Insulin injectors sold filled with insulin; Isotopes for medical purposes; Media for bacteriological cultures; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical preparations for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for oncology, rheumatoid arthritis, diabetes and metabolic disorders; Micro-nutrient preparations for the prevention of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Oxytocics; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of oncology; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of metabolic disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for oncology, rheumatoid arthritis, diabetes and metabolic disorders; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, elixirs for the treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of joint disease; Preparations for detecting genetic predispositions for medical purposes; Preparations for detecting mutation in prion genes for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Radiation sickness treating agents; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radioactive substances for use in nuclear medicine; Radiological contrast substances for medical purposes; Radiopharmaceutical agents for use in amyloid pathology detection; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Stem cells for medical or veterinary use; Test strips for measuring blood glucose levels; Therapeutic spell kits comprising potions and herbs used for oncology, rheumatoid arthritis, diabetes and metabolic disorders; Topical gel for medical and therapeutic treatment of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Tumor suppressing agents
Goods and Services
Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research information in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-03-03
Primary Code
042
First Use Anywhere Date
2015-06-22
First Use In Commerce Date
2016-03-31
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
ZUMUTOR BIOLOGICS INC
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2016-03-03NEW APPLICATION ENTERED IN TRAM
2016-03-03NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-03-04NOTICE OF DESIGN SEARCH CODE E-MAILED
2016-06-10ASSIGNED TO EXAMINER
2016-06-10NON-FINAL ACTION WRITTEN
2016-06-10NON-FINAL ACTION E-MAILED
2016-06-10NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-10-28TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-11-08ASSIGNED TO LIE
2016-11-22CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-11-22TEAS/EMAIL CORRESPONDENCE ENTERED
2016-11-23APPROVED FOR PUB - PRINCIPAL REGISTER
2016-11-29LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-12-14NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-01-03PUBLISHED FOR OPPOSITION
2017-01-03OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-02-28NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-08-28TEAS STATEMENT OF USE RECEIVED
2017-09-14CASE ASSIGNED TO INTENT TO USE PARALEGAL
2017-08-28USE AMENDMENT FILED
2017-09-20STATEMENT OF USE PROCESSING COMPLETE
2017-09-26ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2017-09-27NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2017-10-31REGISTERED-PRINCIPAL REGISTER